| Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease A Ghosh, A Roy, X Liu, JH Kordower, EJ Mufson, DM Hartley, S Ghosh, ... Proceedings of the National Academy of Sciences 104 (47), 18754-18759, 2007 | 515 | 2007 |
| Oxidative stress and the pathogenesis of neurodegenerative disorders A Reynolds, C Laurie, RL Mosley, HE Gendelman International review of neurobiology 82, 297-325, 2007 | 509 | 2007 |
| Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson’s disease RL Mosley, EJ Benner, I Kadiu, M Thomas, MD Boska, K Hasan, C Laurie, ... Clinical neuroscience research 6 (5), 261-281, 2006 | 482 | 2006 |
| Neuroprotective activities of CD4+ CD25+ regulatory T cells in an animal model of Parkinson’s disease AD Reynolds, R Banerjee, J Liu, HE Gendelman, R Lee Mosley Journal of Leucocyte Biology 82 (5), 1083-1094, 2007 | 417 | 2007 |
| Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson’s disease AD Reynolds, DK Stone, JAL Hutter, EJ Benner, RL Mosley, ... The Journal of Immunology 184 (5), 2261-2271, 2010 | 411 | 2010 |
| Nitrated α–synuclein immunity accelerates degeneration of nigral dopaminergic neurons EJ Benner, R Banerjee, AD Reynolds, S Sherman, VM Pisarev, ... PloS one 3 (1), e1376, 2008 | 399 | 2008 |
| Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease EJ Benner, RL Mosley, CJ Destache, TB Lewis, V Jackson-Lewis, ... Proceedings of the National Academy of Sciences 101 (25), 9435-9440, 2004 | 368 | 2004 |
| CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson’s disease JAH Saunders, KA Estes, LM Kosloski, HE Allen, KM Dempsey, ... Journal of Neuroimmune Pharmacology 7, 927-938, 2012 | 317 | 2012 |
| Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice PK Dash, R Kaminski, R Bella, H Su, S Mathews, TM Ahooyi, C Chen, ... Nature communications 10 (1), 1-20, 2019 | 298 | 2019 |
| Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery H Dou, CJ Destache, JR Morehead, RL Mosley, MD Boska, J Kingsley, ... Blood 108 (8), 2827-2835, 2006 | 293 | 2006 |
| Inflammation and adaptive immunity in Parkinson’s disease RL Mosley, JA Hutter-Saunders, DK Stone, HE Gendelman Cold Spring Harbor perspectives in medicine 2 (1), a009381, 2012 | 287 | 2012 |
| Nitrated alpha‐synuclein‐activated microglial profiling for Parkinson’s disease AD Reynolds, JG Glanzer, I Kadiu, M Ricardo‐Dukelow, A Chaudhuri, ... Journal of neurochemistry 104 (6), 1504-1525, 2008 | 276 | 2008 |
| Nitrated α-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets AD Reynolds, DK Stone, RL Mosley, HE Gendelman The Journal of Immunology 182 (7), 4137-4149, 2009 | 236 | 2009 |
| A Macrophage− Nanozyme delivery system for Parkinson's disease EV Batrakova, S Li, AD Reynolds, RL Mosley, TK Bronich, AV Kabanov, ... Bioconjugate chemistry 18 (5), 1498-1506, 2007 | 227 | 2007 |
| Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice R Banerjee, RL Mosley, AD Reynolds, A Dhar, V Jackson-Lewis, ... PloS one 3 (7), e2740, 2008 | 221 | 2008 |
| Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers EV Batrakova, S Li, AM Brynskikh, AK Sharma, Y Li, M Boska, N Gong, ... Journal of controlled release 143 (3), 290-301, 2010 | 203 | 2010 |
| Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson’s disease AM Brynskikh, Y Zhao, RL Mosley, S Li, MD Boska, NL Klyachko, ... Nanomedicine 5 (3), 379-396, 2010 | 190 | 2010 |
| Differentiation and functional maturation of bone marrow-derived intestinal epithelial T cells expressing membrane T cell receptor in athymic radiation chimeras. RL Mosley, D Styre, JR Klein Journal of immunology (Baltimore, Md.: 1950) 145 (5), 1369-1375, 1990 | 184 | 1990 |
| Neuromagnetic evidence of abnormal movement-related beta desynchronization in Parkinson's disease E Heinrichs-Graham, TW Wilson, PM Santamaria, SK Heithoff, ... Cerebral cortex 24 (10), 2669-2678, 2014 | 174 | 2014 |
| Innate and adaptive immunity for the pathobiology of Parkinson's disease DK Stone, AD Reynolds, RL Mosley, HE Gendelman Antioxidants & redox signaling 11 (9), 2151-2166, 2009 | 162 | 2009 |
Howard E. GendelmanProfessor and Chair, Pharmacology & Experimental Neuroscience, University of Nebraska Medical Center在 unmc.edu 的电子邮件经过验证
